Meryem Alagöz

541 total citations
17 papers, 430 citations indexed

About

Meryem Alagöz is a scholar working on Molecular Biology, Oncology and Pathology and Forensic Medicine. According to data from OpenAlex, Meryem Alagöz has authored 17 papers receiving a total of 430 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 5 papers in Oncology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Meryem Alagöz's work include DNA Repair Mechanisms (3 papers), Cancer therapeutics and mechanisms (3 papers) and Reproductive Biology and Fertility (2 papers). Meryem Alagöz is often cited by papers focused on DNA Repair Mechanisms (3 papers), Cancer therapeutics and mechanisms (3 papers) and Reproductive Biology and Fertility (2 papers). Meryem Alagöz collaborates with scholars based in Türkiye, United Kingdom and Egypt. Meryem Alagöz's co-authors include Sherif F. El‐Khamisy, Owen S. Wells, Duncan C. Gilbert, Anthony J. Chalmers, Penny A. Jeggo, Shih‐Chieh Chiang, Abhishek Sharma, Hideaki Ogiwara, Andreas Kakarougkas and Atsushi Shibata and has published in prestigious journals such as Nucleic Acids Research, PLoS ONE and British Journal of Cancer.

In The Last Decade

Meryem Alagöz

17 papers receiving 424 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Meryem Alagöz Türkiye 10 336 119 62 42 38 17 430
Elangovan Thavathiru United States 12 219 0.7× 92 0.8× 50 0.8× 59 1.4× 28 0.7× 16 371
Maribel Lara‐Chica Spain 10 169 0.5× 61 0.5× 35 0.6× 63 1.5× 55 1.4× 13 301
Suzanne B.R. Jacobs United States 9 312 0.9× 60 0.5× 94 1.5× 69 1.6× 67 1.8× 11 476
Jidong Shan United States 11 248 0.7× 75 0.6× 27 0.4× 55 1.3× 18 0.5× 18 357
Nune Markosyan United States 10 123 0.4× 247 2.1× 51 0.8× 66 1.6× 28 0.7× 14 486
Arindam Paul United States 8 300 0.9× 66 0.6× 88 1.4× 75 1.8× 18 0.5× 8 398
Hideki Matsuzaki Japan 11 401 1.2× 96 0.8× 41 0.7× 34 0.8× 45 1.2× 14 558
Deborah Rotoli Italy 11 267 0.8× 34 0.3× 26 0.4× 39 0.9× 44 1.2× 24 398
Mai Tsuchiya Japan 10 247 0.7× 73 0.6× 36 0.6× 40 1.0× 8 0.2× 29 367
Heather N. Andrews Canada 8 250 0.7× 150 1.3× 108 1.7× 80 1.9× 15 0.4× 14 404

Countries citing papers authored by Meryem Alagöz

Since Specialization
Citations

This map shows the geographic impact of Meryem Alagöz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meryem Alagöz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meryem Alagöz more than expected).

Fields of papers citing papers by Meryem Alagöz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meryem Alagöz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meryem Alagöz. The network helps show where Meryem Alagöz may publish in the future.

Co-authorship network of co-authors of Meryem Alagöz

This figure shows the co-authorship network connecting the top 25 collaborators of Meryem Alagöz. A scholar is included among the top collaborators of Meryem Alagöz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meryem Alagöz. Meryem Alagöz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Keskin, İlknur, et al.. (2024). Preliminary study on the impact of 900 MHz radiation on human sperm: An in vitro molecular approach. Reproductive Toxicology. 130. 108744–108744. 1 indexed citations
2.
Alagöz, Meryem, et al.. (2020). Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review). International Journal of Molecular Medicine. 46(2). 521–534. 18 indexed citations
3.
Alagöz, Meryem, et al.. (2020). The New CIC Mutation Associates with Mental Retardation and Severity of Seizure in Turkish Child with a Rare Class I Glucose-6-Phosphate Dehydrogenase Deficiency. Journal of Molecular Neuroscience. 70(12). 2077–2084. 3 indexed citations
4.
Alagöz, Meryem, et al.. (2020). New mutations in KCNT2 gene causing early infantile epileptic encephalopathy type 57: Case study and literature review. Acta Biochimica Polonica. 67(3). 431–434. 5 indexed citations
5.
Alagöz, Meryem, et al.. (2020). A novel mutation in the SERAC1 gene correlates with the severe manifestation of the MEGDEL phenotype, as revealed by whole‑exome sequencing. Experimental and Therapeutic Medicine. 19(6). 3505–3512. 5 indexed citations
6.
Alagöz, Meryem, et al.. (2019). New Genetic Approaches for Early Diagnosis and Treatment of Autism Spectrum Disorders. Review Journal of Autism and Developmental Disorders. 6(4). 367–380. 1 indexed citations
7.
İrez, Tülay, et al.. (2018). The use of aniline blue chromatin condensation test on prediction of pregnancy in mild male factor and unexplained male infertility. Andrologia. 50(10). e13111–e13111. 10 indexed citations
9.
Alagöz, Meryem, Y Katsuki, Hideaki Ogiwara, et al.. (2015). SETDB1, HP1 and SUV39 promote repositioning of 53BP1 to extend resection during homologous recombination in G2 cells. Nucleic Acids Research. 43(16). 7931–7944. 67 indexed citations
10.
Alagöz, Meryem, Owen S. Wells, & Sherif F. El‐Khamisy. (2013). TDP1 deficiency sensitizes human cells to base damage via distinct topoisomerase I and PARP mechanisms with potential applications for cancer therapy. Nucleic Acids Research. 42(5). 3089–3103. 56 indexed citations
11.
Alagöz, Meryem, Shih‐Chieh Chiang, Abhishek Sharma, & Sherif F. El‐Khamisy. (2013). ATM Deficiency Results in Accumulation of DNA-Topoisomerase I Covalent Intermediates in Neural Cells. PLoS ONE. 8(4). e58239–e58239. 61 indexed citations
12.
Stiff, Tom, Meryem Alagöz, Diana Alcantara, et al.. (2013). Deficiency in Origin Licensing Proteins Impairs Cilia Formation: Implications for the Aetiology of Meier-Gorlin Syndrome. PLoS Genetics. 9(3). e1003360–e1003360. 52 indexed citations
13.
Alagöz, Meryem, Duncan C. Gilbert, Sherif F. El‐Khamisy, & Anthony J. Chalmers. (2012). DNA Repair and Resistance to Topoisomerase I Inhibitors: Mechanisms, Biomarkers and Therapeutic Targets. Current Medicinal Chemistry. 19(23). 3874–3885. 72 indexed citations
14.
Fırat, Mehmet Ziya, et al.. (2011). Gyrate atrophy of the choroid and retina with hyperornithinemia, cystinuria and lysinuria responsive to vitamin B6. BMJ Case Reports. 2011. bcr0720103200–bcr0720103200. 10 indexed citations
15.
Tavassoli, M, Herdis Steingrimsdottir, Eric A. Pierce, et al.. (1996). Loss of heterozygosity on chromosome 5q in ovarian cancer is frequently accompanied by TP53 mutation and identifies a tumour suppressor gene locus at 5q13.1-21. British Journal of Cancer. 74(1). 115–119. 44 indexed citations
16.
Tavassoli, Mahvash, et al.. (1995). LOSS OF WILD-TYPE P53 AND C-ERBB2 AMPLIFICATION CORRELATES WITH HIGH-GRADE BREAST CARCINOMAS. International Journal of Oncology. 6(1). 181–6. 2 indexed citations
17.
İrez, Tülay, et al.. (1992). Effects of indoleamines on sperm motility in vitro. Human Reproduction. 7(7). 987–990. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026